Impaired insulin-like growth factor I vasorelaxant effects in hypertension

Hypertension

Volumn 37, Issue 6, 2001, Pages 1480-1485

  Vecchione, Carmine ^a   Colella, Salvatore ^a   Fratta, Luigi ^a   Gentile, Maria Teresa ^a   Selvetella, Giulio ^a   Frati, Giacomo ^a   Trimarco, Bruno ^a   Lembo, Giuseppe ^a  

^a IRCCS NEUROMED   (Italy)

Author keywords

Aorta; Nitric oxide; Norepinephrine; Receptors, adrenergic, alpha; Vascular reactivity

Indexed keywords

SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; GENE TARGETING; HYPERTENSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; VASODILATATION;

EID: 0035572703     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.37.6.1480     Document Type: Article

References (40)

1. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism
2. IGF-1 is required for normal embryonic growth in mice
3. Insulin-like growth factor I exerts growth hormone- and insulin-like actions on human muscle protein metabolism
4. Insulin and insulin-like growth factor I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms
5. Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism
6. Receptors and growth-promoting effects of insulin and insulin-like growth factor I on cell from bovine retinal capillaries and aorta
7. Regulation of insulin-like growth factor I and its receptor in rat aorta after balloon denudation: Evidence for local bioactivity
8. Increase in insulin-like growth factor I in hypertrophying smooth muscle
9. Angiotensin II stimulates gene expression of cardiac insulin growth factor I and its receptor through effects on blood pressure and food intake
10. Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats
11. Recombinant human insulin-like growth factor I increases forearm blood flow
12. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring
13. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide
14. Insulin and insulin-like growth factor I cause coronary vasorelaxation in vitro
15. Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypercholesterolemia
16. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency
17. Growth factor expression in aorta of normotensive and hypertensive rats
18. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells
19. Molecular and cellular aspects of the insulin-like growth factor I receptor
20. Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta
21. Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta
22. Insulin and insulin-like growth factor I in normal and pathological cardiovascular physiology
23. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: Direct measurement in vascular endothelial cells
24. Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size
25. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle
26. Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: A cGMO-independent effect
27. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase
28. Modulation of renal hemodynamics by IGF-1 is absent in spontaneously hypertensive rats
29. Influence of age on inotropic response to insulin and insulin like growth factor-1 in spontaneously hypertensive rats: Role of nitric oxide
30. Influence of age on contractile response to insulin-like growth factor 1 in ventricular myocytes from spontaneously hypertensive rats
31. Alterations to the nitric oxide pathway in the spontaneously hypertensive rats
32. Nitric oxide dependent vasodilation in young spontaneously hypertensive rats
33. C-AMP-dependent protein kinase and lipolysis in rat adipocytes, III: Multiple modes of insulin responses by adenylate cyclase regulators
34. Studies on alpha-adrenergic activation of hepatic glucose output: Insulin inhibition of alpha-adrenergic and glucagon actions in normal and calcium-depleted hepatocytes
35. iα2
36. Insulin blunts sympathetic vasoconstriction through the alpha-2 adrenergic pathway in humans
37. Insulin enhances endothelial alpha-2 adrenergic vasorelaxation by a pertussis toxin mechanism
38. Mechanisms of noradrenaline-induced vasorelaxation in isolated femoral arteries of the neonatal rat
39. Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans
40. Insulin modulation of endothelial nitric oxide component in the alpha2-and beta-adrenergic responses in human forearm